Cystatin C as an antagonist of TGF-B and methods related thereto

Details for Australian Patent Application No. 2012200038 (hide)

Owner National Jewish Health

Inventors Schiemann, William P.

Agent Freehills

Pub. Number AU-A-2012200038

Parent 2004281152

Filing date 4 January 2012

Wipo publication date 2 February 2012

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

19 January 2012 Complete Application Filed

2 February 2012 Application Open to Public Inspection

  Published as AU-A-2012200038

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200039-Carbon dioxide separating and recovering system and method of controlling the same

2012200037-Systems, methods, and apparatus for providing security services utilizing a smart utility meter